Literature DB >> 17288553

Structural studies of thymidine kinases from Bacillus anthracis and Bacillus cereus provide insights into quaternary structure and conformational changes upon substrate binding.

Urszula Kosinska1, Cecilia Carnrot, Michael P B Sandrini, Anders R Clausen, Liya Wang, Jure Piskur, Staffan Eriksson, Hans Eklund.   

Abstract

Thymidine kinase (TK) is the key enzyme in salvaging thymidine to produce thymidine monophosphate. Owing to its ability to phosphorylate nucleoside analogue prodrugs, TK has gained attention as a rate-limiting drug activator. We describe the structures of two bacterial TKs, one from the pathogen Bacillus anthracis in complex with the substrate dT, and the second from the food-poison-associated Bacillus cereus in complex with the feedback inhibitor dTTP. Interestingly, in contrast with previous structures of TK in complex with dTTP, in this study dTTP occupies the phosphate donor site and not the phosphate acceptor site. This results in several conformational changes compared with TK structures described previously. One of the differences is the way tetramers are formed. Unlike B. anthracis TK, B. cereus TK shows a loose tetramer. Moreover, the lasso-domain is in open conformation in B. cereus TK without any substrate in the active site, whereas in B. anthracis TK the loop conformation is closed and thymidine occupies the active site. Another conformational difference lies within a region of 20 residues that we refer to as phosphate-binding beta-hairpin. The phosphate-binding beta-hairpin seems to be a flexible region of the enzyme which becomes ordered upon formation of hydrogen bonds to the alpha-phosphate of the phosphate donor, dTTP. In addition to descriptions of the different conformations that TK may adopt during the course of reaction, the oligomeric state of the enzyme is investigated.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17288553     DOI: 10.1111/j.1742-4658.2006.05617.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  7 in total

1.  Exploiting temperature-dependent substrate promiscuity for nucleoside analogue activation by thymidine kinase from Thermotoga maritima.

Authors:  Stefan Lutz; Joseph Lichter; Lingfeng Liu
Journal:  J Am Chem Soc       Date:  2007-06-26       Impact factor: 15.419

2.  Quaternary structure change as a mechanism for the regulation of thymidine kinase 1-like enzymes.

Authors:  Dario Segura-Peña; Joseph Lichter; Manuela Trani; Manfred Konrad; Arnon Lavie; Stefan Lutz
Journal:  Structure       Date:  2007-12       Impact factor: 5.006

3.  Synthesis and evaluation of thymidine kinase 1-targeting carboranyl pyrimidine nucleoside analogs for boron neutron capture therapy of cancer.

Authors:  Hitesh K Agarwal; Ahmed Khalil; Keisuke Ishita; Weilian Yang; Robin J Nakkula; Lai-Chu Wu; Tehane Ali; Rohit Tiwari; Youngjoo Byun; Rolf F Barth; Werner Tjarks
Journal:  Eur J Med Chem       Date:  2015-05-27       Impact factor: 6.514

Review 4.  N3-substituted thymidine bioconjugates for cancer therapy and imaging.

Authors:  Ahmed Khalil; Keisuke Ishita; Tehane Ali; Werner Tjarks
Journal:  Future Med Chem       Date:  2013-04       Impact factor: 3.808

5.  Synthesis of N3-substituted carboranyl thymidine bioconjugates and their evaluation as substrates of recombinant human thymidine kinase 1.

Authors:  Hitesh K Agarwal; Craig A McElroy; Elena Sjuvarsson; Staffan Eriksson; Michael V Darby; Werner Tjarks
Journal:  Eur J Med Chem       Date:  2012-12-05       Impact factor: 6.514

6.  Structural and Kinetic Characterization of Thymidine Kinase from Leishmania major.

Authors:  Jennifer Timm; Cristina Bosch-Navarrete; Eliseo Recio; Joanne E Nettleship; Heather Rada; Dolores González-Pacanowska; Keith S Wilson
Journal:  PLoS Negl Trop Dis       Date:  2015-05-15

7.  A general method for directly phasing diffraction data from high-solvent-content protein crystals.

Authors:  Richard Lawrence Kingston; Rick P Millane
Journal:  IUCrJ       Date:  2022-08-13       Impact factor: 5.588

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.